$7.47 Billion Endoscope - Radiofrequency Ablation Markets to 2025: Analysis by Application - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 19, 2018--The “Endoscope - Radiofrequency Ablation Market by Application - Global Opportunity Analysis and Industry Forecast, 2017-2025” report has been added to ResearchAndMarkets.com’s offering.
According to the report, the global endoscope + radiofrequency ablation (RFA) market was valued at $3,567 million in 2017 and is projected to reach $7,471 million by 2025, growing at a CAGR of 9.6% from 2018 to 2025. North America was the highest revenue contributor in 2017 and is expected to maintain this trend throughout the forecast period.The global endoscope + RFA market is anticipated to grow at a significant rate during the forecast period, owing to factors, such as increase in the prevalence of cancer and cardiac ailments across the globe, surge in adoption of RFA devices in pain management, and high efficacy and short duration of the procedure.However, high costs associated with the RFA treatment and limited awareness towards available endoscopic RFA devices are anticipated to hamper the market growth. On the contrary, the emerging indications for the endoscopic radiofrequency ablation are expected to offer lucrative growth opportunities for the market players.
On the basis of application, the market is classified into cardiology application, pain management, oncology application, and other application. Among these, the cardiology application segment accounted for the largest share of the revenue generated in 2017 and is anticipated to maintain this trend throughout the forecast period. However, the oncology application segment is expected to grow at the fastest pace from 2018 to 2025.
Key FindingsThe pain management segment accounted for approximately 29% of the global market share in 2017.Europe accounted for more than 30% share of the global endoscope + RFA market in 2017 and is expected to maintain this trend throughout the forecast period.India is anticipated to grow at the fastest pace in the Asia-Pacific market, registering a CAGR of 12.8% from 2018 to 2025.U.S. has generated the highest revenue in 2017 in the North America market and is expected to maintain this dominance throughout the forecast period.
Key Topics Covered
Chapter 1: Introduction
Chapter 2: Executive Summary
Chapter 3: Market Overview
Chapter 4: Endoscope + Radiofrequency Ablation (RFA) Market, by Application
Chapter 5: Company ProfilesBoston Scientific CorporationConmed CorporationMedtronic plcSmith & Nephew plcStryker Corporation
For more information about this report visit https://www.researchandmarkets.com/research/hpzh9m/7_47_billion?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180919005268/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Medical Devices,Nuclear Medicine and Radiopharmacology,Endoscopy
INDUSTRY KEYWORD: HEALTH RADIOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/19/2018 04:33 AM/DISC: 09/19/2018 04:33 AM